- Home
- RMBS vs CORT Comparison
RMBS vs CORT Comparison
Compare RMBS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBS
- CORT
- Stock Information
- Founded
- RMBS 1990
- CORT 1998
- Country
- RMBS United States
- CORT United States
- Employees
- RMBS N/A
- CORT N/A
- Industry
- RMBS Semiconductors
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- RMBS Technology
- CORT Health Care
- Exchange
- RMBS Nasdaq
- CORT Nasdaq
- Market Cap
- RMBS N/A
- CORT 7.5B
- IPO Year
- RMBS 1997
- CORT N/A
- Fundamental
- Price
- RMBS $63.07
- CORT $72.93
- Analyst Decision
- RMBS Strong Buy
- CORT Strong Buy
- Analyst Count
- RMBS 4
- CORT 4
- Target Price
- RMBS $78.25
- CORT $142.00
- AVG Volume (30 Days)
- RMBS 856.8K
- CORT 1.6M
- Earning Date
- RMBS 07-28-2025
- CORT 07-28-2025
- Dividend Yield
- RMBS N/A
- CORT N/A
- EPS Growth
- RMBS N/A
- CORT 8.36
- EPS
- RMBS 1.91
- CORT 1.14
- Revenue
- RMBS $605,417,000.00
- CORT $685,446,000.00
- Revenue This Year
- RMBS $26.07
- CORT $35.83
- Revenue Next Year
- RMBS $12.64
- CORT $35.24
- P/E Ratio
- RMBS $33.52
- CORT $62.92
- Revenue Growth
- RMBS 30.13
- CORT 30.93
- 52 Week Low
- RMBS $37.43
- CORT $30.77
- 52 Week High
- RMBS $69.15
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- RMBS 61.90
- CORT 50.50
- Support Level
- RMBS $63.55
- CORT $66.49
- Resistance Level
- RMBS $65.76
- CORT $72.49
- Average True Range (ATR)
- RMBS 1.69
- CORT 2.85
- MACD
- RMBS -0.12
- CORT -0.09
- Stochastic Oscillator
- RMBS 73.87
- CORT 49.95
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.